Ramez Mohsen, managing director at Janssen for Egypt, Jordan, Libya & Sudan, highlights how the company is driving real access to treatments in Egypt through collaboration with various stakeholders. He also assesses Egypt’s attractiveness for clinical trials and the initial results of the government’s prioritization of healthcare.
As the science is moving rapidly, Janssen Egypt is focusing on ongoing medical education, by bringing innovative new ideas to the physicians and meeting their needs by also using digital channels
